Baseline TMTV and Dmax prognostic value in patients with advanced melanoma treated with first-line immune checkpoint inhibitors

被引：0
|
作者：
Vercellino, L. [1 ]
Jallerat, P. [1 ]
Delyon, J. [1 ]
Martineau, A. [1 ]
Baroudjian, B. [1 ]
Poudroux, W. [1 ]
Lebbe, C. [1 ]
Merlet, P. [1 ]
机构：
[1] Hop St Louis, Paris, France
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2022年 / 49卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-693
引用
收藏
页码：S231 / S231
页数：1
相关论文
共 50 条
  • [31] Prognostic value of the timing of immune checkpoint inhibitors infusion in patients with advanced hepatocellular carcinoma
    Pascale, Alina
    Allard, Marc Antoine
    Benamar, Amal
    Levy, Francis
    Adam, Rene
    Rosmorduc, Olivier
    JOURNAL OF HEPATOLOGY, 2024, 80 : S452 - S452
  • [32] Prognostic value of the timing of immune checkpoint inhibitors infusion in patients with advanced hepatocellular carcinoma
    Pascale, Alina
    Allard, Marc Antoine
    Benamar, Amal
    Levi, Francis
    Adam, Rene
    Rosmorduc, Olivier
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 457 - 457
  • [33] The Combining of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Stage Hepatocellular Carcinoma
    Lee, Shou-Wu
    Yang, Sheng-Shun
    Lien, Han-Chung
    Peng, Yen-Chun
    Tung, Chun-Fang
    Lee, Teng-Yu
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (16)
  • [34] Delayed immune-related adverse events in patients with advanced melanoma treated with immune checkpoint inhibitors
    Angeles, Arkhjamil
    Sonke, Eric
    Thao Phuong Nguyen
    Bahl, Gaurav
    Poon, Vincent Isaac
    Bernstein, Vanessa
    Weppler, Alison Margaret
    Savage, Kerry J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [35] Prognostic factors for patients with advanced renal cell carcinoma (aRCC) in the era of first-line (1L) treatment with immune checkpoint inhibitors (ICIs).
    Mantia, Charlene
    Jegede, Opeyemi
    Regan, Meredith M.
    Atkins, Michael B.
    McDermott, David F.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [36] Neutrophil to lymphocyte ratio (NLR) as a prognostic biomarker in melanoma patients treated with immune checkpoint inhibitors
    Oey, O.
    Wijaya, W.
    Khattak, M. A.
    Abed, A.
    Meniawy, T.
    Reid, A.
    Calapre, L.
    Millward, M.
    Gray, E. S.
    ANNALS OF ONCOLOGY, 2024, 35 : S1686 - S1686
  • [37] Is microsatellite-instability a prognostic factor in melanoma patients treated with immune-checkpoint inhibitors?
    Koeller, M.
    Berger, M.
    Eder, S.
    Richtig, G.
    Richtig, E.
    Pichler, M.
    Winter, G.
    Hoefler, G.
    Aigelsreiter, A.
    VIRCHOWS ARCHIV, 2018, 473 : S9 - S10
  • [38] Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma
    Parent, Pauline
    Auclin, Edouard
    Patrikidou, Anna
    Mezquita, Laura
    Chanza, Nieves Martinez
    Dumont, Clement
    Rodriguez-Vida, Alejo
    Llacer, Casilda
    Lozano, Rebeca
    Ratta, Raffaele
    Merseburger, Axel S.
    Sternberg, Cora N.
    Baciarello, Giulia
    Colomba, Emeline
    Fuerea, Alina
    Besse, Benjamin
    Loriot, Yohann
    Lavaud, Pernelle
    CANCERS, 2023, 15 (04)
  • [39] Surgery in patients with metastatic melanoma treated with immune checkpoint inhibitors
    Janssen, Josephine C.
    Huibers, Anne E.
    Grunhagen, Dirk J.
    Bagge, Roger Olofsson
    SCANDINAVIAN JOURNAL OF SURGERY, 2025,
  • [40] Pan-immune inflammation value as a prognostic biomarker for cancer patients treated with immune checkpoint inhibitors
    Kuang, Tianrui
    Qiu, Zhendong
    Wang, Kunpeng
    Zhang, Lilong
    Dong, Keshuai
    Wang, Weixing
    FRONTIERS IN IMMUNOLOGY, 2024, 15
12345